Tempest Therapeutics Inc(NASDAQ:TPST) 
Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated mechanisms with the potential to treat various tumors. The company is headquartered in South San Francisco, California.
Website: https://www.tempesttx.com/
Founded: 2011
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 9.23
H 9.23
L 7.80
C 7.93
V 1,400,029
10EMA 7.93
20EMA 7.93
60EMA 7.93
120EMA 7.93
250EMA 7.93